Echolight Medical awarded Vizient contract to provide improved technology in bone density diagnostics.

Echolight Medical, an innovator in bone health technology, has been awarded a multi-year contract with Vizient Inc,, to make its Radiofrequency Echographic Multi Spectrometry (REMS) technology available at contracted pricing to its members, which represent more than half of the health care organizations across the United States. Widely used throughout Europe, REMS is a radiation-free technology delivered using a portable bone densitometer that can safely monitor key bone health indicators with greater frequency than other testing methods. Within minutes, REMS provides a patient’s bone health scores and an assessment of their future fracture risk.

REMS is the first clinically available method for the direct non-ionizing measurement of BMD at the femur and lumbar spine. Its portability allows for screening and monitoring of patients’ bone health at the point-of-care, improving early diagnosis and prevention of osteoporosis-related fractures.

“This is a major step in achieving our goal of delivering the most precise bone health assessment technology to clinicians at the point-of-care,” said Doug Tefft, Echolight Medical president. Echolight, founded in Italy in 2011, recently expanded its global reach to the United States with the opening of its Seattle headquarters in 2020. “Contracted pricing with Vizient will enable far more people increased access to state-of-the-art bone health assessment technology, at a time when there is a high risk of bone fracture among more than half of Americans age 50 and older.” Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute health care providers. Vizient membership represents more than $100 billion in annual purchasing volume.

About REMS: Portable, diagnostic, radiation-free bone health densitometer – a safe, accurate, and cost-effective medical device elevating bone health awareness and treatment to mainstream medical care. Radiofrequency Echographic Multi Spectrometry (REMS) measures bone density; and reports T-score, Z-score, and a qualitative assessment of bone microarchitecture, independent of bone density, to predict future fracture risk – all provided in minutes. Learn more at echolightmedical.com.

Landis – Message & media

Echolight in the UK

Echolight in the UK

Echolight continues its expansion around the world. Today EchoS, the only radiation free device for the bone assessment on the lumbar vertebrae and the femoral neck, is marketed in more than 30 countries, thanks to the network of distributors located in different...

leggi tutto
Advisory Board Meeting

Advisory Board Meeting

III Meeting of the Echolight International Scientific Board, 4 February, 2020, Geneva. On February 4th, the III Meeting of the Echolight International Scientific Board was held in the beautiful city of Geneva, chaired by Professor Maria Luisa Brandi, with the special...

leggi tutto
Welcome to Professor Cortet

Welcome to Professor Cortet

New member of the International Scientific Board. We are pleased to introduce Professor Bernard CORTET as a new member of our International Scientific Advisory Board. All the other board members were pleased to welcome Professor Cortet given his outstanding scientific...

leggi tutto

    Contattaci

    Maggiori info su Echos o prenota una demo.



    Posizione*

    *Campi obbligatori


    Questo sito è protetto da reCAPTCHA, il suo utilizzo è soggetto alla Privacy Policy e ai termini di utilizzo di Google.

    Copyright © 2021 - Echolight S.p.a Tutti i diritti riservati